Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tvardi Therapeutics, Inc. - Common Stock (NQ:TVRD)

5.410 -0.300 (-5.25%)
Streaming Delayed Price Updated: 12:28 PM EDT, Oct 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 259,644
Open 5.750
Bid (Size) 5.370 (3)
Ask (Size) 5.450 (2)
Prev. Close 5.710
Today's Range 5.270 - 5.900
52wk Range 5.570 - 43.65
Shares Outstanding 1,524,535
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unusual volume stocks in Monday's session
In today's session, these stocks are experiencing unusual volume. 
Via Chartmill
In today's session, these stocks are experiencing unusual volume.
Unusual volume stocks are being observed in Thursday's session. 
Via Chartmill

Performance

YTD
-70.4%
-70.4%
1 Month
-85.5%
-85.5%
3 Month
-78.7%
-78.7%
6 Month
-72.2%
-72.2%
1 Year
-70.4%
-70.4%

More News

Read More
Unusual volume stocks in Wednesday's session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
From Faruqi & Faruqi, LLP
Via Business Wire
Tvardi Therapeutics' Lung Disease Candidate Fails To Show Any Clinical Benefit, Stock Sinks
Via Benzinga
Gold Rises Over 3%; Tvardi Therapeutics Shares Plunge
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Dow Surges 1%; Fastenal Shares Fall After Q3 Results
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Did Tvardi Therapeutics Stock Plummet 87% Pre-Market Today?
Via Stocktwits
Tvardi Therapeutics Provides Update on Preliminary Data from Phase 2 REVERT Trial in Idiopathic Pulmonary Fibrosis
From Tvardi Therapeutics, Inc.
Via Business Wire
Tvardi Therapeutics to Participate in the Cantor Global Healthcare Conference
From Tvardi Therapeutics, Inc.
Via Business Wire
Tvardi Posts Q2 Net Income Turnaround
Via The Motley Fool
Topics Intellectual Property
Tvardi Therapeutics Announces Second Quarter 2025 Results and Provides Business Update
From Tvardi Therapeutics, Inc.
Via Business Wire
Tvardi Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
From Tvardi Therapeutics, Inc.
Via Business Wire
Recently Listed Tvardi Therapeutics' Lead Drug 'Positioned To Drive Broad Improvement', Analyst Sees Over 150% Stock Upside
Via Benzinga
This Modine Manufacturing Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
Tvardi Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of TTI-101 in Idiopathic Pulmonary Fibrosis
From Tvardi Therapeutics, Inc.
Via Business Wire
Tvardi Therapeutics to Participate in Upcoming Investor Conferences
From Tvardi Therapeutics, Inc.
Via Business Wire
Tvardi Therapeutics Announces First Quarter 2025 Results and Provides Business Update
From Tvardi Therapeutics, Inc.
Via Business Wire
Tvardi Therapeutics Announces Presentation at the American Thoracic Society 2025 Annual Conference
From Tvardi Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Coursera Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Frequently Asked Questions

Is Tvardi Therapeutics, Inc. - Common Stock publicly traded?
Yes, Tvardi Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Tvardi Therapeutics, Inc. - Common Stock trade on?
Tvardi Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tvardi Therapeutics, Inc. - Common Stock?
The ticker symbol for Tvardi Therapeutics, Inc. - Common Stock is TVRD on the Nasdaq Stock Market
What is the current price of Tvardi Therapeutics, Inc. - Common Stock?
The current price of Tvardi Therapeutics, Inc. - Common Stock is 5.410
When was Tvardi Therapeutics, Inc. - Common Stock last traded?
The last trade of Tvardi Therapeutics, Inc. - Common Stock was at 10/22/25 12:28 PM ET
What is the market capitalization of Tvardi Therapeutics, Inc. - Common Stock?
The market capitalization of Tvardi Therapeutics, Inc. - Common Stock is 8.25M
How many shares of Tvardi Therapeutics, Inc. - Common Stock are outstanding?
Tvardi Therapeutics, Inc. - Common Stock has 8M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.